¹⁸F-FDG MicroPET and MRI Targeting Breast Cancer Mouse Model with Designed Synthesis Nanoparticles

Figure 4

Optical imaging: (a) control, (b) 15 minutes after injection of Gln-SiGdNPs, and (c) isolated organs.

(a)

(b)

(c)

(d)

(e)

(f)

(g)